|本期目录/Table of Contents|

[1]陈曦.IgG4 相关性胆管炎23 例临床研究[J].慢性病学杂志,2016,(07):791-793.
点击复制

IgG4 相关性胆管炎23 例临床研究(PDF)

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:
期数:
2016年07期
页码:
791-793
栏目:
专题报道
出版日期:
2016-08-27

文章信息/Info

Title:
-
作者:
陈曦
郑州大学第五附属医院，郑州450052
Author(s):
-
关键词:
IgG4; 胆管炎; 糖皮质激素
Keywords:
-
分类号:
R575.7
DOI:
-
摘要:
目的总结IgG4 相关性胆管炎（IAC） 的临床特点及诊治体会。方法收集2010—2015 年郑州大学第 五附属医院收治的23例患者临床资料，根据患者临床表现、实验室检查、免疫血清学检查、影像学、病理学及糖 皮质激素治疗情况等各项指标进行回顾性分析。结果23 例IAC 患者主要临床表现为黄疸（78.26%）、上腹部 不适或疼痛（69.57%），可有乏力、纳差、体质量减轻、皮肤瘙痒伴随症状。实验室检查以总胆红素及碱性磷酸 酶轻中度升高为主；免疫血清学以IgG4水平升高为主要特征；经内镜逆行性胰胆管造影术（ERCP） 及磁共振成 像胆胰管造影（MRCP） 检查以胆管下段狭窄多见；正规糖皮质激素治疗有效率为69.57%。结论IAC 缺乏特 异性的临床表现，早期诊断困难误诊率高。应综合分析临床表现、血清学检查、影像学及病理学等检查结果明确 诊断，减少不必要的手术治疗。
Abstract:
-

参考文献/References:

[1] Bj?rnsson E, Chari ST, Smyrk TC, et al. Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature [J]. Hepatology, 2007,45(6):1547-1554.
[2] Ohara H, Okazaki K, Tsubouchi H, et al. Clinical diagnosticcriteria of IgG4- related sclerosing cholangitis [J]. J Hepatobiliary Pancreat Sci, 2012,19(5):536-542.
[3] Chinese Society Hepatology, Chinese Medical Association. Digestive disease branch of Chinese Medical Association. Anabysis of live biochemicaltesls and monitoring consensus (draft) [J]. Chinese Medical Association Ninth National Conference on Digestive Diseases, 2009:38-45.
[4] Kawa S, Ota M, Yoshizawa K, et al. HLA DRBl0405- DQBl0401 haplotype is associated with autoiannune pancreatitis in the Japanese population [J]. Gastroenterology, 2002,122(5):1264-1269.
[5] Zen Y, Fujii T, Harada K. Th2 and regulatory immune reactions are increased in immunoglobin G4- related selemsing pancreatitis and cholangitis [J]. Hepatology, 2007,5(6):1538-1546.
[6] 田艳丽.免疫球蛋白G4相关性胆管炎诊断和治疗进展[J].中华肝 脏病杂志,2011,19(11):873-875.
[7] Boonstra K, Culver EL, de Buy Wenniger LM, et al. Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4- associated cholangitis from primary sclerosing cholangitis [J]. Hepatology, 2014,59(5): 1954-1963.
[8] Maillette de Buy Wenniger LJ, Doorenspleet ME, Klarenbeek PL, et al. Immunoglobulin G4 + clones identified by next- generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis [J]. Hepatology, 2013,57(6):2390-2398.
[9] Kalaitzakis E, Levy M, Kamisawa T, et al. Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma [J]. Clin Gastroenterol Hepatol, 2011,9(9):800-803.
[10] Smyrk TC. Pathological features of IgG4- related sclerosing disease [J]. Curr Opin Rheumatol, 2011,23(1):74-79.
[11] Hart PA, Topazian MD, Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience [J]. Gut, 2013,62(1):1607-1605.
[12] You MW, Kim JH, Byun JH, et al. Relapse of IgG4- related sclerosing cholangitis after steroid therapy: image findings and risk factors [J]. Eur Radiol, 2014,24(5):1039- 1048.
[13] 尹大龙,刘连新,姜洪池,等.IgG4相关胆管炎诊疗进展[J].中国实 用外科学杂志,2014,34(12):1194-1196.
[14] Khosroshahi A, Carruthers MN, Deshpande V, et al. Rituximab for the treatment of IgG4- related disease: lessons from 10 consecutive patients [J]. Medicine, 2012,91 (1):57-66.

备注/Memo

备注/Memo:
作者简介： 陈曦， 大学本科， 副主任医师， 研究方 向：消化内科、消化内科肿瘤、胃肠镜 通信作者：陈曦，E-mail: chenxi06120@163.com
更新日期/Last Update: 2016-08-27